Neuro positions?

Quote


















anonymous said:
Vraylar has 3 to 4 reps in one damn city. How the hell is it way to many reps ? CAPLYTA is actually under on reps, especially if they want to grow marketshare
Click to expand...
And those Vraylar reps are miserable. I didn’t come here to be in a pod. Most of us left that kind of structure to run our own territory. We don’t need more people, we need better leadership.
 






anonymous said:
And those Vraylar reps are miserable. I didn’t come here to be in a pod. Most of us left that kind of structure to run our own territory. We don’t need more people, we need better leadership.
Click to expand...


When you look at the big picture there’s no way 1 damn person can benefit a drug and gain share. You hire one person per territory and that’s a disaster long term for a drug. Are you sure you people have a college degree ? If you want to truly run your own business go do that but there’s no way 1 person will win long term vs 3 to 4 reps. To me 2 is a perfect number in a territory to effectively sell and grow a drug.
 






anonymous said:
When you look at the big picture there’s no way 1 damn person can benefit a drug and gain share. You hire one person per territory and that’s a disaster long term for a drug. Are you sure you people have a college degree ? If you want to truly run your own business go do that but there’s no way 1 person will win long term vs 3 to 4 reps. To me 2 is a perfect number in a territory to effectively sell and grow a drug.
Click to expand...
In what sunshine fantasy do you believe any reps actually sell any drugs today?
 


















It doesn’t matter the drug. Right message to the right doctor with the right frequency via the right channel is the key to success. It sounds old fashioned but it has proven to work over and over again. The key is making sure you have all those ‘rights’ correct. Is marketing providing the right message and are reps delivering it correctly. Has the analytics team identified the right targets and optimized the call frequency (and are reps adhering to that frequency) and is the message getting to the HCP. Is the message staying in the HCP’s head enough for them to remember.
 






anonymous said:
When you look at the big picture there’s no way 1 damn person can benefit a drug and gain share. You hire one person per territory and that’s a disaster long term for a drug. Are you sure you people have a college degree ? If you want to truly run your own business go do that but there’s no way 1 person will win long term vs 3 to 4 reps. To me 2 is a perfect number in a territory to effectively sell and grow a drug.
Click to expand...
My last job before ITCI, I sold a rare disease drug that was nearly $2BB a year. One rep per territory. We were successful and owned the market and share. You don’t need multiple reps in a territory. That approach worked in the early 2000s. With the influence of managed care and hospital systems, more reps doesn’t equal more prescriptions.

Reps who like pods are usually pretenders who want to hide and collect a check while they pick the kids up from school at 3:00.
 






JnJ isn't keeping 90% of the reps..... we don't need 50 reps per territory. We already have two (Schiz/Mood). If anything they'll use a internal med sales force for those accounts. Other than that no over lays.
 












anonymous said:
JnJ isn't keeping 90% of the reps..... we don't need 50 reps per territory. We already have two (Schiz/Mood). If anything they'll use an internal med sales force for those accounts. Other than that no over lays.
Click to expand...
Help me understand why JnJ would have us continue with the expansion efforts then? The cost to hire, train, etc then to only offer these reps severance seems idiotic.

They invested billions in an attempt to make CAP successful. Why waste more money by hiring then displacing people.
 






anonymous said:
Help me understand why JnJ would have us continue with the expansion efforts then? The cost to hire, train, etc then to only offer these reps severance seems idiotic.

They invested billions in an attempt to make CAP successful. Why waste more money by hiring then displacing people.
Click to expand...
They will keep much of the PCP team and probably release most of the NSS because they already have two psych reps per territory. Plus, companies do this all the time right up until the date the deal closes. Continue with business as usual. The deal could fall through last minute so we need to press on as if there is no deal. If JnJ were to back out, they have to pay out a “poison pill” penalty likely worth more than $100,000,000. Business as usual to keep the plebes working as though our jobs depend on it.
 






anonymous said:
They will keep much of the PCP team and probably release most of the NSS because they already have two psych reps per territory. Plus, companies do this all the time right up until the date the deal closes. Continue with business as usual. The deal could fall through last minute so we need to press on as if there is no deal. If JnJ were to back out, they have to pay out a “poison pill” penalty likely worth more than $100,000,000. Business as usual to keep the plebes working as though our jobs depend on it.
Click to expand...


Bookmark it, screenshot it, put it on your refrigerator.

No ITCI reps(NSS or NSR) will be laid off in a mass layoff event this year or next. Anyone saying otherwise is just plain dumb.
 


















anonymous said:
Bookmark it, screenshot it, put it on your refrigerator.

No ITCI reps(NSS or NSR) will be laid off in a mass layoff event this year or next. Anyone saying otherwise is just plain dumb.
Click to expand...
Stupid middle manager doing the company’s bidding. Keep em grinding big shot. Make that extra call every day. Use the challenger model to close for that next patient. Find that “one thing” that makes you so special and use it to your advantage. There is no way JnJ would cull such a uniquely talented specialty sales force. Except we aren’t unique and they have their own psych team carrying a drug that’s going generic. Do the math. Or don’t and just wait for the axe to fall. I can’t wait for all the “leaders” here to be out on their ass. A lot more jobs for us reps than there are for you bloated, useless managers. Counting the days until I get my payout.
 












anonymous said:
Stupid middle manager doing the company’s bidding. Keep em grinding big shot. Make that extra call every day. Use the challenger model to close for that next patient. Find that “one thing” that makes you so special and use it to your advantage. There is no way JnJ would cull such a uniquely talented specialty sales force. Except we aren’t unique and they have their own psych team carrying a drug that’s going generic. Do the math. Or don’t and just wait for the axe to fall. I can’t wait for all the “leaders” here to be out on their ass. A lot more jobs for us reps than there are for you bloated, useless managers. Counting the days until I get my payout.
Click to expand...

Not a manager at all... I'm just someone who isn't retarded. Anyone who's launched a drug in the past 20 years will tell you im right. All you first-job-in-pharma-ba-in-communications-grads are literally clueless. Barring something totally unexpected in the mdd label or the launch-- there won't be any layoffs for the foreseeable future.
 






Top Bottom
Back
Quote